期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Low-dose and high-dose ^(131)I therapy for low and intermediate risk differentiated thyroid cancer: a randomized controlled clinical study
1
作者 瞿源 《China Medical Abstracts(Internal Medicine)》 2017年第1期20-21,共2页
Objective To compare the ablation efficacy and therapy response with low-dose(1.1 GBq)and high-dose(3.7 GBq) 131I in postoperative patients with low and in-termediate risk DTC.Methods A total of 140 patients(37 m... Objective To compare the ablation efficacy and therapy response with low-dose(1.1 GBq)and high-dose(3.7 GBq) 131I in postoperative patients with low and in-termediate risk DTC.Methods A total of 140 patients(37 males,103 females,age range:18-75 years)were enrolled from October 2014 to June 2015,and 展开更多
关键词 HIGH a randomized controlled clinical study Low-dose and high-dose I therapy for low and intermediate risk differentiated thyroid cancer
原文传递
A Randomized Double-blind Placebo-controlled Study of Pu'er Tea(普洱茶) Extract on the Regulation of Metabolic Syndrome 被引量:13
2
作者 褚松龄 富宏 +5 位作者 杨金霞 刘庚信 窦攀 张良 屠鹏飞 王学美 《Chinese Journal of Integrative Medicine》 SCIE CAS 2011年第7期492-498,共7页
Objective:To explore the regulative efficacy of Pu'er tea(普洱茶)extract on metabolic syndrome. Methods:Ninety patients with metabolic syndrome were randomly divided into two groups,the intervention group adminis... Objective:To explore the regulative efficacy of Pu'er tea(普洱茶)extract on metabolic syndrome. Methods:Ninety patients with metabolic syndrome were randomly divided into two groups,the intervention group administered with Pu'er tea extract,and the placebo group with placebo capsules.After 3 months' treatment, body mass index,waist hip ratio,blood lipids,blood sugar,immune and inflammatory index,and oxidation index of the patients with metabolic syndrome were tested and analyzed.Results:In the intervention group,the body mass index,waist-hip ratio,fasting and 2 h postprandial blood glucose,serum total cholesterol,triglycerides, low density lipoprotein and apolipoprotein B-100 all decreased in the patients with metabolic syndrome,and also the high-density lipoprotein level increased and apolipoprotein A-1 showed the tendency to increase. Serum C-reactive protein,tumor necrosis factor-α,and interleukin-6 were decreased in the intervention group. lnterleukin-10 level was increased,MDA was decreased and superoxide dismutase was increased.Compared with before treatment and the placebo group,there were significant differences(P0.05,P0.01).Conclusions: Pu'er tea demonstrated excellent potential in improving central obesity,adjusting blood lipid,lowering blood sugar,regulating immunity and resisting oxidation.It can adjust the metabolic syndrome of different clinical phenotypes to different degrees,and is ideally fit for early prevention of metabolic syndrome. 展开更多
关键词 TEA metabolic syndrome randomized controlled clinical study
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部